NCT06620653Recruiting
Heart Failure Virtual Ward Research Study
Source: ClinicalTrials.gov · Last updated 15 Apr 2026
Brief summary (registry, in English)
The main aim will be to evaluate whether a follow-up with virtual wards reduces HF hospitalisation at three months follow-up. Hospital admission will be defined as any hospital admission, or an emergency room stay of more than 24 h requiring IV diuretics. The secondary objectives will be to evaluate whether this intervention reduces all-cause mortality, all-cause hospitalisation at three months, is cost-effectiveness, is associated with a higher percentage of prescription and dose of prognostic medication and improves the quality of life. To assess the potential long-term effects of the virtual wards follow-up, we will evaluate whether this intervention reduces all-cause mortality and HF hospitalisation at 6- and 12-months by a telephone call/virtual outpatients' appointment. The study outcomes will be ascertained at each visit. Given the study design, it is impossible to assess the endpoints in a blinded manner. Clinical events during the study will be adjudicated by an operational committee whose members will be unaware of the group assignment.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 346 (estimated)
- First submitted
- 23 Jul 2024
- Start date
- 18 Oct 2024
- Primary completion date
- Feb 2027
- Lead sponsor
- National University of Ireland, Galway, Ireland
- Diseases
- Heart failure
- NCT number
- NCT06620653
What you commit to
- Study type: Interventional
- Planned participants: 346
- From 18 Oct 2024 to the primary completion date, Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who, at the investigator's discretion, are considered unable to participate in the study, mainly due to a previous history of non- compliance with medication and follow-up appointments, language barrier, or moderate or severe cognitive impairment without the support of a family member/caregiver.
Other illness
- Patients with asymptomatic (NYHA class I) left ventricular dysfunction, usually in the setting of an acute myocardial infarction.
Other
- Patients who decline to participate in the study.
- Patient in palliative care or with a life expectancy of less than one year.
- Patients referred to skilled nursing facilities or nursing homes at hospital discharge.
- Patients with planned intervention on the mitral or aortic valve during admission or scheduled early after discharge.
- Planned haemodialysis.
- Patients included in other randomized controlled trials.
- The lack of information technology (IT) literacy will not be an exclusion criterion.
Who the study is looking for
- Adult patients (≥ 18 years) with a recent hospitalisation.
- Known ejection fraction and NYHA Class
- Known or de novo Heart Failure
- Patient or carer able to speak and understand English/Irish
- Willing to participate in the study.
- Within catchment area of the Saolta group.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Portiuncula University Hospital Coordinator of this site? Confirm its status | Ballinasloe | Ireland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.